FDA ANDA · ANDA200152

ARMODAFINIL

Sponsor: TEVA PHARMS USA INC

APPLICATION

ANDA200152

TYPE

ANDA

ROUTE

ORAL

DOSAGE FORM

TABLET

MARKETING STATUS

None (Tentative Approval)

Products

ARMODAFINILNone (Tentative Approval)

ARMODAFINIL 250MG · TABLET · ORAL

ARMODAFINILNone (Tentative Approval)

ARMODAFINIL 150MG · TABLET · ORAL

ARMODAFINILNone (Tentative Approval)

ARMODAFINIL 50MG · TABLET · ORAL

ARMODAFINILNone (Tentative Approval)

ARMODAFINIL 200MG · TABLET · ORAL

ARMODAFINILNone (Tentative Approval)

ARMODAFINIL 100MG · TABLET · ORAL

2014-09-24OriginalTA

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.